UnitedHealth’s 4-Star Medicare Enrollment Share Falls to 67%, J.P. Morgan Estimates: What It Means Before Earnings

Gian Estrada • 3 minute read
Reviewed by: David Hanson
Last updated Oct 10, 2026

 Ivan Chumak from Pexels and 89Stocker via Canva

Friday’s gain suggests investors are treating the ratings as a 2028 problem. Tuesday’s call gives management an opportunity to clarify how many members are in downgraded plans and discuss the potential financial impact. better?

UnitedHealth (UNH) shares rose about 2% on Friday to close at $379.30, even though the new 2027 Medicare Advantage star ratings point to a worse result for the insurer.

J.P. Morgan estimates the share of UnitedHealth members in plans rated four stars or higher will fall to about 67% for 2027, from about 81%. UnitedHealth said Thursday that the ratings were in line with its expectations. The enrollment estimate comes from J.P. Morgan’s analysis of the CMS ratings.

Above Average to Below It

The drop matters more because the industry moved the other way. CMS says about 71% of Medicare Advantage drug plan enrollees will be in four-star-or-better contracts for 2027, up from about 67%. UnitedHealth went from beating that average to trailing it.

CMS also changed the scoring, adding two medication-safety measures and tripling the weight of physical and mental health measures. Part of the slide may reflect new rules rather than worse care. The bonus effect lands in 2028, not 2027.

Humana (HUM) shows the other side. Humana reported 95% of its Medicare Advantage members in four-star-or-better plans for 2027, compared with the 20% initially reported for 2026. Its stock closed Friday up about 11.6%.

UnitedHealth Has More Room Than Humana

unitedhealth stock ebit margin
UNH Stock EBIT Margin (TIKR)

UnitedHealth’s EBIT margin fell from 8.1% in 2024 to 4.8% in 2025, then edged up to 5.3% on an LTM basis.

That’s a sharp drop, but it still leaves more than double Humana’s 2.3%. UnitedHealth also runs Optum, so Medicare Advantage is a smaller slice of the business. A smaller bonus hurts, but it isn’t the whole story here the way it is at Humana.

unitedhealth stock street analysts targets
UNH Stock Street Analysts Targets (TIKR)

The Street still leans bullish. The mean target of $481 sits about 27% above Friday’s close, with 15 buys, 7 outperforms and 4 holds.

UnitedHealth’s October 13 Call Matters More Now

UnitedHealth reports third-quarter results before the market opens on Tuesday, October 13.

Tuesday’s call gives management an opportunity to clarify how many members are in downgraded plans and discuss the potential financial impact.

Want to see how UnitedHealth’s margins and Street targets shift after Tuesday? Track both on TIKR for free. Learn more here.

So what is UnitedHealth Group stock actually worth?


TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what UNH stock could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value UnitedHealth Group Incorporated for free→

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required